| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
GNE-781 manufacturers
- GNE-781
-
- $140.00
-
2026-07-20
- CAS:1936422-33-1
- Purity: 99.92%
- Supply Ability: 10g
|
| | GNE-781 Basic information |
| Product Name: | GNE-781 | | Synonyms: | GNE-781;5H-Pyrazolo[4,3-c]pyridine-5-carboxamide, 3-[7-(difluoromethyl)-3,4-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-1(2H)-quinolinyl]-1,4,6,7-tetrahydro-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-;3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide;3- (7-(difluoromethyl)-6-(1-methylpyrazol-4-yl)-3.4-dihydro-2H-quinohn-1-yl]-N-methyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4.3-c]pyridine-5-carboxamide;GNE-781,Histone Acetyltransferase,Inhibitor,HATs,Epigenetic Reader Domain,GNE 781,HAT,inhibit,GNE781;GNE-781, 10 mM in DMSO | | CAS: | 1936422-33-1 | | MF: | C27H33F2N7O2 | | MW: | 525.59 | | EINECS: | | | Product Categories: | | | Mol File: | 1936422-33-1.mol |  |
| | GNE-781 Chemical Properties |
| Melting point | 135-140oC | | Boiling point | 800.7±65.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 14.19±0.20(Predicted) | | form | Solid | | color | White to Pale Yellow | | InChIKey | CQCWHSDMJBAGDC-UHFFFAOYSA-N | | SMILES | C1N(C(NC)=O)CCC2N(C3CCOCC3)N=C(N3C4=C(C=C(C5=CN(C)N=C5)C(C(F)F)=C4)CCC3)C1=2 |
| | GNE-781 Usage And Synthesis |
| Uses | GNE-781 is a highly advanced, potent and selective bromodomain inhibitor of cyclic adenosine monophosphate response element binding protein, binding protein (CBP). Inhibition of the bromodomain of the transcriptional regulator CBP/P300 is an especially interesting new therapeutic approach in oncology. | | in vivo | GNE-781 (3-30 mg/kg; p.o.; twice daily for 21 days) has tumor growth inhibition (%TGI) is 73%, 71%, and 89% at 3, 10, and 30 mg/kg, respectively in SCID beige mice with MOLM-16 AML xenografts[1].
GNE-781 decreases Foxp3 transcript levels in a dose dependent manner. GNE-781 (3-30 mg/kg) suppresses MYC at doses as low as 3 mg/kg at 2 and 8 h, with maximal suppression at 10 and 30 mg/kg at 2 h (87% and 88% inhibition, respectively)[1].
|
| | GNE-781 Preparation Products And Raw materials |
|